Marpai (NASDAQ:MRAI) Stock Price Down 3.9% – Time to Sell?
by Doug Wharley · The Cerbat GemMarpai, Inc. (NASDAQ:MRAI – Get Free Report) was down 3.9% on Tuesday . The stock traded as low as $0.4720 and last traded at $0.4901. Approximately 121,522 shares were traded during mid-day trading, an increase of 103% from the average daily volume of 59,891 shares. The stock had previously closed at $0.5101.
Marpai Stock Performance
The stock has a market capitalization of $9.84 million, a PE ratio of -0.15 and a beta of 4.71. The business’s 50-day moving average price is $0.55 and its 200 day moving average price is $0.92.
Marpai Company Profile
Marpai Inc is a technology-driven healthcare benefits management company that leverages data analytics and artificial intelligence to optimize health outcomes and control costs for self-insured employers. Its flagship Marpai Health Platform integrates personalized care pathways, advanced member engagement tools and real-time claims analytics. By combining machine learning models with clinical expertise, Marpai identifies risk patterns early and guides members toward cost-effective, high-quality care.
Marpai’s suite of services encompasses underwriting, care coordination, pharmacy benefits management and virtual health coaching, all delivered through a unified digital interface.